Tuberculosis and human immunodeficiency virus co-infection in children: management challenges

被引:21
作者
Chintu, Chifumbe [1 ]
机构
[1] Univ Zambia, Sch Med, Dept Paediat & Child Hlth, Lusaka, Zambia
关键词
tuberculosis; HIV; antiretroviral therapy; isoniazid prophylaxis;
D O I
10.1016/j.prrv.2007.05.003
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The pattern of childhood human immunodeficiency virus (HIV) and tuberculosis (TB) infection mirror these epidemics in the adult population. The number of children co-infected with HIV and TB is rising, and the incidence of congenital and neonatal TB is similarly increasing. In addition, the emergence of multidrug resistant TB and extensively drug-resistant TB has occurred within the context of a high prevalence of HIV and TB. The diagnosis of TB has always been difficult in children and is compounded by HIV co-infection. The clinical symptoms in both diseases are similar, and the radiological changes may be non-specific. Treatment of both conditions in children is a challenge due to drug interactions and problems with adherence. In most developing countries, there are few medicines specifically tested and manufactured for children, with few stable syrup formulations. Thus antituberculosis and antiretroviral tablets have to be divided, giving rise to unpredictable dosing and the possible emergence of resistance. To reduce the morbidity and mortality of TB and HIV, existing childhood TB programmes must be strengthened, and antiretroviral drug therapy and mother-to-child transmission programmes scaled up. An increased emphasis on childhood TB, with early diagnosis and treatment, must be a priority. The provision of isoniazid prophylaxis to HIV-infected children exposed to an adult case of TB or, in areas with a high prevalence of TB, to HIV-infected children (irrespective of a TB contact) may be effective in reducing the morbidity and mortality from childhood TB. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:142 / 147
页数:6
相关论文
共 50 条
[31]   The cost to health services of human immunodeficiency virus (HIV) co-infection among tuberculosis patients in Sudan [J].
El-Sony, AI .
HEALTH POLICY, 2006, 75 (03) :272-279
[32]   Association of TAP 1 and 2 gene polymorphisms with human immunodeficiency virus-tuberculosis co-infection [J].
Sunder, Sharada Ramaseri ;
Hanumanth, Surekha Rani ;
Gaddam, Sumanlatha ;
Jonnalagada, Subbanna ;
Valluri, Vijaya Lakshmi .
HUMAN IMMUNOLOGY, 2011, 72 (10) :908-911
[33]   Mycobacterium tuberculosis and human lymphotropic virus, a fatal co-infection [J].
Morales, Juan ;
Montero, Leonardo .
REVISTA CHILENA DE INFECTOLOGIA, 2024, 41 (02) :307-310
[34]   Management of tuberculosis and latent tuberculosis infection in human immunodeficiency virus-infected persons [J].
Lee, Shui Shan ;
Meintjes, Graeme ;
Kamarulzaman, Adeeba ;
Leung, Chi Chiu .
RESPIROLOGY, 2013, 18 (06) :912-922
[35]   Advances in the Treatment of Human Immunodeficiency Virus and Hepatitis B Virus Co-infection [J].
Guofang Sun .
Infection International, 2016, 5 (02) :54-58
[36]   Tuberculosis and HIV co-infection in children [J].
Venturini, Elisabetta ;
Turkova, Anna ;
Chiappini, Elena ;
Galli, Luisa ;
de Martino, Maurizio ;
Thorne, Claire .
BMC INFECTIOUS DISEASES, 2014, 14
[37]   Subacute Sclerosing Panencephalitis in a Child with Human Immunodeficiency Virus Co-Infection [J].
Maurya, Pradeep Kumar ;
Thakkar, Mayur Deepak ;
Kulshreshtha, Dinkar ;
Singh, Ajai Kumar ;
Thacker, Anup Kumar .
CLINICAL MEDICINE & RESEARCH, 2016, 14 (3-4) :156-158
[38]   Monkeypox and chickenpox co-infection in a person living with Human Immunodeficiency Virus [J].
Mmerem, Juliet, I ;
Johnson, Simon M. ;
Iroezindu, Michael O. .
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2024, 18 (07) :1152-1156
[39]   Identification potential epigenetic biomarkers of a human immunodeficiency virus/tuberculosis co-infection based on weighted gene co-expression network analysis [J].
Xu, Shaohua ;
Yuan, Huicheng ;
Li, Ling ;
Bai, Feng ;
Yang, Kai ;
Zhao, Liangcun .
MICROBIOLOGY AND IMMUNOLOGY, 2021, 65 (10) :422-431
[40]   Management of tuberculosis and HIV co-infection in Cotonou, Benin [J].
Agodokpessi, G. ;
Ade, G. ;
Ade, S. ;
Wachinou, A. P. ;
Affolabi, D. ;
Anagonou, S. ;
Gninafon, M. .
MEDECINE ET MALADIES INFECTIEUSES, 2012, 42 (11) :561-566